Revised SPC: Rydapt (midostaurin) 25 mg soft capsules

Rydapt should not be used in combination with intensive paediatric AML combination chemotherapy regimens including anthracyclines, fludarabine and cytarabine because of the risk of prolonged haematological recovery (such as prolonged severe neutropenia and thrombocytopenia).

electronic Medicines compendium